Short- and long-term outcomes after small-bore needle arthroscopic removal of fragmented portions of the medial coronoid process for treatment of dogs with medial coronoid process disease

Le résumé fourni par la source

Aims To report short- and long-term outcomes of dogs with medial coronoid process disease (MCPD) treated by needle arthroscopy-assisted fragment removal (NA-FR) and to identify potential tomodensitometric and arthroscopic criteria associated with functional prognosis.Methods Medical records of dogs diagnosed with MCPD by CT and presented to a single veterinary teaching hospital, between 2021 and 2023 and treated with NA-FR were retrospectively reviewed. Data collected and analysed included: subjective lameness scores (0–5 scale) evaluated by surgeons before, and 15 days and 1 month after surgery; modified International Elbow Working Group (mIEWG; 0–12 scale) score determined by CT, modified Outerbridge score (MOS, 0–5 scale) assessed during surgery; and Canine Orthopaedic Index (COI; 16–80 scale) scores collected from owners at the time of presentation, 1 month after surgery and at long-term follow-up (≥ 12 months).Results Data from 41 clinically affected elbows (30 dogs) diagnosed with MCPD by CT were included. A decrease in lameness scores compared to before surgery was observed at 15 days (2 (IQR 2–3) vs. 0 (IQR 0–1); p = 0.05) and 30 days post-operatively (2 (IQR 2–3) vs. 0 (IQR 0–2); p = 0.0002). Dogs that were still lame 30 days post-operatively had a higher ulnar MOS than those that were no longer lame (3 (IQR 3–4) vs. 2 (IQR 2–3); p = 0.02). At long-term follow-up (median 24 (IQR 16–32) months after surgery; available for 18/30 dogs), there was a reduction in COI scores (median 21 (IQR 19–24)) compared to the pre-operative period (median 48 (IQR 45–56); p = 0.002). Furthermore, COI scores were higher in dogs having an ulnar or humeral MOS > 2 or mIEWG > 6 compared to those having an ulnar or humeral MOS ≤ 2 or mIEWG ≤ 6 (28 (IQR 25–44) vs. 19 (IQR 18–21), p = 0.004 and 26 (IQR 25–28) vs. 19 (IQR 19–23), p = 0.02).Conclusions and clinical relevance MCPD treated by NA-FR showed satisfactory short- and long-term post-operative outcomes. Increased humeral or ulnar MOS scores as well as modified IEWG scores were associated in our study with a poorer long-term outcome. Further assessments are needed to validate this strategy and to establish the criteria for identifying dogs that will best benefit from NA-FR.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.